The use of the proteolytic enzyme brinase to produce autocytotoxicity in patients with acute leukemia and its possible role in immunotherapy.
D000328:Adult; D000917:Antibody Formation; D001230:Aspergillus / Q000201:enzymology; D001323:Autoantibodies; D001792:Blood Platelets / Q000276:immunology; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D003165:Complement System Proteins; D003429:Cross Reactions; D003601:Cytotoxicity Tests, Immunologic; D004338:Drug Combinations; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000276:immunology*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology; D008247:Lysosomes; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000627:therapeutic use
D001323:Autoantibodies; D004338:Drug Combinations; D003165:Complement System Proteins; D010447:Peptide Hydrolases